399 related articles for article (PubMed ID: 3278425)
1. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD
Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425
[TBL] [Abstract][Full Text] [Related]
2. Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts.
Kerman RH; Van Buren CT; Lewis RM; Kahan BD
Transplantation; 1988 Jan; 45(1):37-40. PubMed ID: 3276059
[TBL] [Abstract][Full Text] [Related]
3. The relationship among donor-recipient HLA mismatches, rejection, and death from coronary artery disease in cardiac transplant recipients.
Kerman RH; Kimball P; Scheinen S; Radovancevic B; Van Buren CT; Kahan BD; Frazier OH
Transplantation; 1994 Mar; 57(6):884-8. PubMed ID: 8154036
[TBL] [Abstract][Full Text] [Related]
4. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients.
Kerman RH; Kimball PM; Van Buren CT; Lewis RM; Kahan BD
Transplantation; 1991 Feb; 51(2):338-42. PubMed ID: 1825242
[TBL] [Abstract][Full Text] [Related]
5. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival.
Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD
Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130
[TBL] [Abstract][Full Text] [Related]
6. Successful transplantation of cyclosporine-treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatches.
Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
Transplantation; 1985 Dec; 40(6):615-9. PubMed ID: 3907031
[TBL] [Abstract][Full Text] [Related]
7. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
8. The effect of zero HLA class I and II mismatching in cyclosporine-treated kidney transplant patients.
Cicciarelli J; Terasaki PI; Mickey MR
Transplantation; 1987 May; 43(5):636-40. PubMed ID: 3554654
[TBL] [Abstract][Full Text] [Related]
9. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
[TBL] [Abstract][Full Text] [Related]
10. Investigation of HTLV-3 serology in a renal transplant population.
Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Dawson G; Falk L; Gutierrez R; Hollinger JB; Kahan BD
Transplantation; 1987 Feb; 43(2):244-8. PubMed ID: 3544383
[TBL] [Abstract][Full Text] [Related]
11. Immunoregulatory mechanisms in cyclosporine-treated renal allograft recipients.
Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
Transplantation; 1987 Feb; 43(2):205-10. PubMed ID: 2949404
[TBL] [Abstract][Full Text] [Related]
12. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
Kerman RH; Van Buren CT; Lewis RM; Kahan BD
Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254
[No Abstract] [Full Text] [Related]
13. Successful DR-incompatible cadaver kidney transplantation. Combined effect of HLA A and B matching and blood transfusion.
Schulak JA; Goeken NE; Nghiem DD; Corry RJ
Transplantation; 1984 Dec; 38(6):649-53. PubMed ID: 6390828
[TBL] [Abstract][Full Text] [Related]
14. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
Laufer G; Miholic J; Laczkovics A; Wollenek G; Holzinger C; Hajek-Rosenmeier A; Wuzl G; Schreiner W; Buxbaum P; Wolner E
J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
[TBL] [Abstract][Full Text] [Related]
15. Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients.
Kerman RH; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Gerolami K; Kahan BD
Transplantation; 1990 Jan; 49(1):52-6. PubMed ID: 2301027
[TBL] [Abstract][Full Text] [Related]
16. The influence of histocompatibility on graft rejection and graft survival within a single center population of heart transplant recipients.
Sheldon S; Yonan NA; Aziz TN; Hasleton PS; Rahman AN; Deiraniya AK; Campbell CS; Dyer PA
Transplantation; 1999 Aug; 68(4):515-9. PubMed ID: 10480409
[TBL] [Abstract][Full Text] [Related]
17. Immunologic monitoring of the beneficial effect of one HLA-DR-shared blood transfusion in heart transplant patients.
Vaessen LM; van Miert PP; van der Mast BJ; Doumaid K; Balk AH; Boog CJ; Weimar W
J Heart Lung Transplant; 2000 Nov; 19(11):1098-107. PubMed ID: 11077228
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome.
Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM
Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489
[TBL] [Abstract][Full Text] [Related]
19. Survival of cadaveric donor renal allografts in cyclosporine A-treated recipients: the influence of HLA-DR antigen matching.
Madsen M; Fjeldborg O; Graugaard B; Posborg V; Kissmeyer-Nielsen F
Transplant Proc; 1988 Jun; 20(3):369-71. PubMed ID: 3381251
[No Abstract] [Full Text] [Related]
20. AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival.
Kerman RH; Kimball PM; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Heydari A; Kahan BD
Transplantation; 1991 Feb; 51(2):316-20. PubMed ID: 1994522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
